1-20 of 232
b-cell acute lymphocytic leukemia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation

Clinical Trials & Observations
Jingyan Tang, Jie Yu, Jiaoyang Cai, Li Zhang, Shaoyan Hu, Ju Gao, Hua Jiang, Yongjun Fang, Changda Liang, Xiuli Ju, Runming Jin, Xiaowen Zhai, Xuedong Wu, Xin Tian, Qun Hu, Ningling Wang, Hui Jiang, Lirong Sun, Alex W. K. Leung, Minghua Yang, Kaili Pan, Cheng Cheng, Yiping Zhu, Hui Zhang, Chunfu Li, Jun J. Yang, Chi-kong Li, Xiaofan Zhu, Shuhong Shen, Ching-Hon Pui
Journal: Blood
Blood (2021) 138 (4): 331–343.
https://doi.org/10.1182/blood.2020010438
Published: 2021
Includes: Supplemental data
Journal Articles

Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study

Clinical Trials & Observations
Francisco Pedrosa, Elaine Coustan-Smith, Yinmei Zhou, Cheng Cheng, Arli Pedrosa, Mecneide Mendes Lins, Marcia Pedrosa, Norma Lucena-Silva, Alessandra Maria de Luna Ramos, Ester Vinhas, Gaston K. Rivera, Dario Campana, Raul C. Ribeiro
Journal: Blood
Blood (2020) 135 (17): 1458–1466.
https://doi.org/10.1182/blood.2019004215
Published: 2020
Includes: Supplemental data
Journal Articles

Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin

Talha Badar, MD, Aniko Szabo, PhD, Martha Wadleigh, MD, Michaela Liedtke, MD, Shukaib Arslan, MD, Caitlin Siebenaller, PharmD, Ibrahim Aldoss, MD, Elizabeth Schultz, Mehrdad Hefazi, MD, Mark Litzow, MD, Eric Kuo, Amy Wang, MD MPH, Emily K Curran, MD, Rory M Shallis, MD, Nikolai A. Podoltsev, MD PhD, Suresh Kumar Balasubramanian, MD, Jay Yang, MD, Ryan J. Mattison, MD, Madelyn Burkart, MD, Shira Dinner, Anjali S. Advani, MD, Ehab L. Atallah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1302.
https://doi.org/10.1182/blood-2019-124882
Published: 2019
Journal Articles

Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a US Hospital's Perspective

Hongbo Yang, Yanni Hao, PhD, Cynthia Z. Qi, MBA, Xinglei Chai, PhD, Eric Q Wu
Journal: Blood
Blood (2019) 134 (Supplement_1): 4723.
https://doi.org/10.1182/blood-2019-129215
Published: 2019
Journal Articles

Preclinical Activity of the MPS1 Inhibitor S81694 in Acute Lymphoblastic Leukemia (ALL)

Anna Kaci, PhD, Emilie Adiceam, Melanie Dupont, Marine Garrido, Jeannig Berrou, Hanane Djamai, Andre Baruchel, Mike Burbridge, Claude Gardin, Herve Dombret, MD PhD, Thorsten Braun, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2631.
https://doi.org/10.1182/blood-2019-125641
Published: 2019
Journal Articles

Hispanic and Black Patients with Adult B-Cell Acute Lymphoblastic Leukemia Have a Significantly Worse Survival in the Modern Era - a SEER 2010-2016 Analysis

Nishi Shah, MBBS, MPH, Mohammad Kazemi, Stephen Zachary Peeke, MD, Lizamarie Bachier-rodriguez, R.Alejandro Sica, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Aditi Shastri, MD, Amit Verma, MBBS, Ioannis Mantzaris, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 426.
https://doi.org/10.1182/blood-2019-123168
Published: 2019
Journal Articles

A Fast and Accurate Diagnostic Method for Ph-like ALL Using the Ncounter System

Kensuke Sasaki, MD, Kohta Miyawaki, MD PhD, Yuichiro Semba, MD PhD, Koji Kato, MD PhD, Jumpei Nogami, PhD, Takeshi Sugio, MD PhD, Toshihiro Miyamoto, MD PhD, Yoshikiyo Ito, MD PhD, Koji Nagafuji, MD PhD, Takahiro Maeda, MD PhD, Koichi Akashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 375.
https://doi.org/10.1182/blood-2019-129625
Published: 2019
Journal Articles

Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Norman J. Lacayo, MD, Vinod A. Pullarkat, MD, Wendy Stock, MD, Elias Jabbour, MD, Ashish Bajel, MBBS, FRACP, FRCPA, Jeffrey Rubnitz, MD PhD, Jessica Leonard, MD, Charles G. Mullighan, MBBS, MD, Seong Lin Khaw, MD, Susan I. Vear, MD MSCI, Joseph T. Opferman, PhD, Ahmed Hamed Salem, PhD FCP, Michelle Schmidt, Bo Tong, PhD, Lang Zhou, PhD, Jeremy A. Ross, PhD, Lindsey Bensman, Amanda Jacobson, PhD, Robin Norris, MD MS, MPH, Thomas Alexander, MDMPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 285.
https://doi.org/10.1182/blood-2019-126977
Published: 2019
Journal Articles

Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Chiara F Magnani, PhD, Giuseppe Gaipa, PhD, Daniela Belotti, Giada Matera, Sarah Tettamanti, PhD, Benedetta Cabiati, Chiara Buracchi, PhD, Grazia Fazio, Silvia Zaninelli, Silvia Rigamonti, Stefania Cesana, Valentina Colombo, Giovanni Cazzaniga, PhD, Attilio Rovelli, MD, Adriana Balduzzi, MD, Sara Napolitano, MD, Fabrizio Benedicenti, Eugenio Montini, PhD, Gian Maria Borleri, Silvia Ferrari, MD, Giuseppe Gritti, MD PhD, Federico Lussana, MD, Martino Introna, MD, Alessandro Rambaldi, MD, Giuseppe Dastoli, MD, Andrea Biondi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 200.
https://doi.org/10.1182/blood-2019-125894
Published: 2019
Journal Articles

High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL

Liping Li, MD PhD, Katharina Hayer, Lingling Xian, MD PhD, Li Luo, PhD, Leslie Cope, Andrei Thomas-Tikhonenko, PhD, Linda Resar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3946.
https://doi.org/10.1182/blood-2019-130261
Published: 2019
Journal Articles

A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies

Hamid Bolouri, PhD, Benjamin K. Johnson, PhD, Rhonda E. Ries, MA, Laura Pardo, Tiffany A. Hylkema, BS, Wanding Zhou, PhD, Jenny L. Smith, MSc, MD, Amanda R. Leonti, MS, Allison Kaeding, MD, Michael R. Loken, PhD, Jason E. Farrar, MD, Soheil Meshinchi, MD PhD, Timothy Junius Triche, Jr., PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3768.
https://doi.org/10.1182/blood-2019-123487
Published: 2019
Journal Articles

Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab

Talha Badar, MD, Aniko Szabo, PhD, Anjali S. Advani, MD, Martha Wadleigh, MD, Shukaib Arslan, MD, Muhammad Khan, Ibrahim Aldoss, MD, Caitlin Siebenaller, PharmD, Elizabeth Schultz, Mehrdad Hefazi, MD, Rory M Shallis, MD, Ilana Yurkiewicz, MD BS, Nikolai A. Podoltsev, MD PhD, Anand Ashwin Patel, MD, Emily K Curran, MD, Suresh Kumar Balasubramanian, MD, Jay Yang, MD, Ryan J. Mattison, MD, Madelyn Burkart, MD, Shira Dinner, Michaela Liedtke, MD, Mark Litzow, MD, Ehab L. Atallah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3809.
https://doi.org/10.1182/blood-2019-125466
Published: 2019
Journal Articles

Pediatric-Inspired Regimens Are Associated with Better Outcomes When Compared with Hypercvad in Hispanic Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Roberta Demichelis, MD, Karla Adriana Espinosa, MD MSc, Juan Rangel-Patiño, MD, Emmanuel Almanza, MD, Ana Cooke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3877.
https://doi.org/10.1182/blood-2019-125370
Published: 2019
Journal Articles

Targeting Neurotrophic Receptor Tyrosine Kinase (NTRK) Fusion Structural Homologs in Refractory Pediatric Acute Lymphoblastic Leukemia (ALL)

Son Tran, Mehul Gupta, Sunand Kannappan, Chunfen Zhang, MD, Aru Narendran, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3882.
https://doi.org/10.1182/blood-2019-132223
Published: 2019
Journal Articles

Real World Chart Review of Blinatumomab to Treat Patients with High Disease Burden of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Amber C. King, PharmD, BCOP, Rachel Bolanos, PhD MPH, Kelly Velasco, PharmD, Huakang Tu, PhD, Faraz Zaman, MD, Mark B. Geyer, MD, Jae H. Park, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5079.
https://doi.org/10.1182/blood-2019-122745
Published: 2019
Journal Articles

A Phase 1 a/b Dose Escalation Trial to Evaluate the Safety and Tolerability of CG-806 in Patients with Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

Stephen B Howell, MD, Hongying Zhang, MD PhD, William G Rice, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5477.
https://doi.org/10.1182/blood-2019-130784
Published: 2019
Journal Articles

Successful Treatment of Refractory Acute Lymphoblastic Leukemia with Tisagenlecleucel in the Setting of Life-Threatening Infection

Keith J August, MDMS, Terrie Flatt, DO,MA, Erin Marie Hall, MD, Doug Myers, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5125.
https://doi.org/10.1182/blood-2019-130880
Published: 2019
Journal Articles

Detection of the Genomic Variants in the Paired De Novo-Relapsed Samples with Pan-Cancer Panel and Whole Exome-Seq in Adult B-Cell Acute Lymphoblastic Leukemia

Zheng Ge, MD PhD, Yuka Imamura Kawasawa, PhD, Yan Gu, MD, Qi Han, MD, Jie Zi, Chunhua Song, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5206.
https://doi.org/10.1182/blood-2019-126750
Published: 2019
Journal Articles

The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia Is a Strong Predictor for Survival

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Xuemei Wang, MS, Joseph D. Khoury, MD, Farhad Ravandi, MD, Jeffrey L. Jorgensen, MD PhD, Nicholas J. Short, MD, Sanam Loghavi, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Koji Sasaki, MD, Marina Y Konopleva, MD PhD, Koichi Takahashi, MD, William G. Wierda, MD PhD, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev E. Estrov, MD, Prithviraj Bose, MD, Sherry A. Pierce, BSN, BA, Rebecca Garris, MSc, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1297.
https://doi.org/10.1182/blood-2019-125913
Published: 2019
Journal Articles

Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A ( MLL ) Rearrangement

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Guilin Tang, MD, C. Cameron Yin, MD PhD, Joseph D. Khoury, MD, Ghayas C. Issa, MD, Nitin Jain, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Courtney D. DiNardo, MDMSc, Koichi Takahashi, MD, Maro Ohanian, DO, Gautam M. Borthakur, MD, Marina Y Konopleva, MD PhD, Naval G. Daver, MD, Zeev E. Estrov, MD, Yesid Alvarado, MD, Alessandra Ferrajoli, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD PhD, Rebecca Garris, MSc, Jorge E. Cortes, MD, Susan O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2582.
https://doi.org/10.1182/blood-2019-130864
Published: 2019